Viewing nowCombinationEmpaanda Duo Tablet 5/1000 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202201298 · Approved 2022.04.04 · Insurance code 657309080
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adults with type 2 diabetes. It is administered as an adjunct to diet and exercise therapy, combining Empagliflozin and Metformin. It is particularly suitable for patients whose blood sugar is not adequately controlled, and those with cardiovascular disease should refer to expert usage precautions. This medication effectively improves blood sugar control and aids in the management of the patient's health.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from concomitant treatment with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin as they were previously taking. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated using the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be closely monitored every 3-6 months (see Precautions for Use 3. Patients Requiring Caution, subsection 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use 2. Patients Who Must Not Take This Medicine, subsection 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be taken into consideration.
This medication consists of two main ingredients that help control blood sugar. Caution is warranted because rare but serious side effects such as severe lactic acidosis may occur when using this medication. There can be a risk of hypoglycemia if taken alongside other diabetes medications, so blood sugar changes should be closely monitored. Patients with moderate to severe decreased kidney function, acute kidney issues, severe infections, or heart failure should not take this medication. It is advisable for women who are pregnant or may become pregnant, nursing mothers, and patients with liver dysfunction not to use this medication. Patients scheduled for surgery should discontinue this medication 48 hours before the surgery, and restart only after kidney function has returned to normal post-surgery. This medication may affect the body’s fluid levels, so caution should be taken if there are symptoms of dehydration or gastrointestinal disturbances. During treatment, urinary tract infections or genital infections may occur; if infection symptoms appear, consult with medical staff immediately. Vitamin B12 deficiency may occur; therefore, patients who take this medication long-term should regularly check their Vitamin B12 levels. Alcohol consumption may increase the risk of lactic acidosis; it is advisable to avoid drinking while taking this medication. In elderly patients, kidney function should be regularly monitored, and use should be cautious in patients at risk of hypotension or fluid loss. In cases of overdose, serious side effects such as lactic acidosis or hypoglycemia may occur, so the dosage must be strictly adhered to. While taking this medication, blood sugar levels and kidney function should be monitored regularly and any abnormal symptoms should be promptly reported to a healthcare professional.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. Storage temperature should be maintained between 1 degree and 30 degrees Celsius to preserve the medication’s efficacy for a longer period.
A yellow, round, biconvex film-coated tablet with a brown hue.
10 tablets/box [10 tablets/PTP x 1], 60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.